ConductScience.org, home

Paper20877293

Vaccine outlooks. After negative publicity and a series of setbacks over HIV/AIDS and influenza, the prospects for research on new vaccines are improving.

Hunter P. EMBO Rep, 2010. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Vaccine outlooks. After negative publicity and a series of setbacks over HIV/AIDS and influenza, the prospects for research on new vaccines are improving. Papers, record 20877293. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20877293

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Vaccine outlooks. After negative publicity and a series of setbacks over HIV/AIDS and influenza, the prospects for research on new vaccines are improving.
PubMed
Journal
EMBO Rep
PubMed
Year
2010
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Relative citation ratio, by iCite
0
iCite
Revised in PubMed
2021-10-20
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hunter PPhilip

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AIDS VaccinesMajor topic
Acquired Immunodeficiency SyndromeMajor topic
Influenza VaccinesMajor topic
Influenza, HumanMajor topic
VaccinationMajor topic
HIV
Humans

Source PubMed

Download CSV of topics

References5

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
120543832Live attenuated influenza virus vaccines by computer-aided rational design.Nat Biotechnol2010https://conductscience.org/library/papers/20543832PubMed
27625118HIV-1 recombinant gp160 vaccine induced antibodies in serum and saliva. The NIAID AIDS Vaccine Clinical Trials Network.Vaccine1995https://conductscience.org/library/papers/7625118PubMed
319843557Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand.N Engl J Med2009https://conductscience.org/library/papers/19843557PubMed
417898737HIV vaccine failure prompts Merck to halt trial.Nature2007https://conductscience.org/library/papers/17898737PubMed
519850226Progress towards a dengue vaccine.Lancet Infect Dis2009https://conductscience.org/library/papers/19850226PubMed

Download CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20877293

GET https://conductscience.org/api/papers/v1/20877293/authors